Hospital prices for services have little consistency

As the Trump administration continues to put forth efforts to reduce drug costs, hospital prices will likely become more transparent. For now, prices remain somewhat obscure—and vary widely for the same procedures, according to an analysis by Axios.

For example, the price for joint replacement surgery, one of the most common inpatient procedures, was at least $30,000 in nine out of 10 hospitals analyzed by Axios. And one of six hospitals charged $90,000 or more, Axios concluded, citing 2016 federal healthcare data.

Hospitals can set procedure prices however they want—and Medicare will pay it. However, Medicare pays less than $13,000 on average for a joint replacement even though prices are “all over the map.”

For-profit hospitals tended to have higher prices, but some not-for-profit hospital systems also had some of the highest prices for joint replacements, according to Axios. And hospitals continually raise their prices to charge even higher rates.

See the full story below:

Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.